Teladoc Health (NYSE: TDOC) announced its 2021 Q2 financial results on July 27th. According to the announcement, total revenue was up 109% (YoY, 3 months). However, Teladoc recorded operating loss and net loss of 78.9 million USD and 133.8 million USD, respectively. In this regard, these amounts of operating loss and net loss were mainly attributable to depreciation and amortization associated with the acquisitions of Livongo and InTouch Health as well as Livongo stock awards that continue to vest after the merger. On the other hand, Teladoc recorded positive operating cash flow and free cash flow in 2021 Q2.
Teladoc’s US paid membership recorded 51 million in 2021 Q2. Considering the population of the US citizens, drastic growth of the US paid membership in the future may be improbable. In this regard, the US paid membership was up 1% (YoY), and it likely plateaued these days.
However, subscription-based access fee revenue was up 138% compared to 2020 Q2 (YoY, 3 months). In addition, it accounts for 91% of the total revenue. These facts suggest soundness and underlying strength of the Teladoc’s revenue.
Recently, Teladoc has launched several services related to chronic care and mental care. Success in these new business segments would be one of the next milestones of the Teladoc’s growth.
As many people know, Teladoc’s stock price has been slumping these days. The future reduction of the net loss might bring further growth in their stock price.
- Watanabe & Brothers’ Investment is holding shares of Teladoc Health.
- This report is provided solely for informational purpose and not intended for the purpose of soliciting investment in, or as a recommendation to purchase or sell any specific products.
- Any opinions or statements expressed in this report are based on the author’s personal and subjective views, and are not the official views of the organization to which the author belongs. In addition, although we have done our best efforts in making accurate assessments on the original financial statements, we cannot guarantee any complete accuracy of this report. We do not guarantee either that any future forecasts referred to in this report will certainly be realized. Investment in listed stocks, ETFs, etc. should be carried out under the responsibility of each investor, and even if the investor who read this report suffers a loss due to investment activities, Watanabe & Brothers’ Investment is not responsible for any liability.
- This report was originally prepared in English, and translated into the other languages with plugin utilizing Google Translation API. We hereby notify that the translations are provided only for the sake of reference, and any opinions or statements in this report should be interpreted in original English. We ask any investors reading this report to refer to the original financial statements issued by the company.